Is VUG a Good ETF to Buy?
For the last few years, earnings growth from the tech…
Buy
67
CPOUF Quote, Financials, Valuation and Earnings
Last price:
$0.75
Seasonality move
:
-10.77%
Day range:
$0.75 - $0.75
52-week range:
$0.44 - $0.75
Dividend yield:
1.76%
P/E ratio:
11.08x
P/S ratio:
0.35x
P/B ratio:
0.81x
Volume:
--
Avg. volume:
--
1-year change:
15.38%
Market cap:
$5.8B
Revenue:
$16.5B
EPS (TTM):
$0.07
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Charoen Pokphand Foods PCL has -- downside to fair value with a price target of -- per share.
CPOUF vs. S&P 500
-
Over the past 5 trading days, Charoen Pokphand Foods PCL has overperformed the S&P 500 by 2.99% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Charoen Pokphand Foods PCL does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Charoen Pokphand Foods PCL has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Charoen Pokphand Foods PCL reported revenues of $4.4B.
Earnings Growth
-
Charoen Pokphand Foods PCL earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Charoen Pokphand Foods PCL reported earnings per share of $0.01.
Enterprise value:
19.7B
EV / Invested capital:
0.90x
Price / LTM sales:
0.35x
EV / EBIT:
22.34x
EV / Revenue:
1.20x
PEG ratio (5yr expected):
0.34x
EV / Free cash flow:
14.28x
Price / Operating cash flow:
4.21x
Enterprise value / EBITDA:
12.26x
Gross Profit (TTM):
$2.5B
Return On Assets:
2.2%
Net Income Margin (TTM):
3.36%
Return On Equity:
6.65%
Return On Invested Capital:
2.55%
Operating Margin:
6.83%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $17.5B | $16.8B | $16.5B | $4.1B | $4.4B | |
| Gross Profit | $2.4B | $1.7B | $2.5B | $311.9M | $676.4M | |
| Operating Income | $811.5M | $178.7M | $1B | -$76.6M | $298M | |
| EBITDA | $1.4B | $751.2M | $1.6B | $262.3M | $412.8M | |
| Diluted EPS | $0.05 | -$0.02 | $0.07 | -$0.00 | $0.01 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $6.5B | $6.5B | $6.7B | $5.7B | $5.9B | |
| Total Assets | $25.4B | $25.3B | $26.8B | $24.3B | $25.6B | |
| Current Liabilities | $6.8B | $6.1B | $7.7B | $7.1B | $7.7B | |
| Total Liabilities | $16.7B | $16.7B | $18.1B | $16.5B | $17.1B | |
| Total Equity | $8.8B | $8.7B | $8.7B | $7.8B | $8.6B | |
| Total Debt | $12.8B | $12.9B | $14B | $13.1B | $13.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $958.7M | $1B | $1.8B | $420.9M | $507.1M | |
| Cash From Investing | -$735.2M | -$562.7M | -$411M | -$228.2M | -$167M | |
| Cash From Financing | -$367.5M | -$553.1M | -$1.4B | -$53.5M | -$319.4M | |
| Free Cash Flow | $168.6M | $374.3M | $1.4B | $223M | $373.6M | |
CPOUF
Sector
Market Cap
$5.8B
$294.3M
Price % of 52-Week High
100%
72.72%
Dividend Yield
1.76%
0%
Shareholder Yield
1.29%
3.14%
1-Year Price Total Return
15.39%
-11.28%
Beta (5-Year)
--
0.465
Dividend yield:
1.76%
Annualized payout:
$0.01
Payout ratio:
24.27%
Growth streak:
1 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$0.75
200-day SMA
Buy
Level
$0.67
Bollinger Bands (100)
Sell
Level
0.74 - 0.76
Chaikin Money Flow
Sell
Level
-3K
20-day SMA
Sell
Level
$0.75
Relative Strength Index (RSI14)
Buy
Level
100.00
ADX Line
Buy
Level
99.87
Williams %R
Sell
Level
0
50-day SMA
Sell
Level
$0.75
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Neutral
Level
14.1K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.0912)
Sell
CA Score
(Annual)
Level (-1.0785)
Buy
Beneish M-Score
(Annual)
Level (-2.8455)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-0.331)
Buy
Piotroski F Score
(Annual)
Level (8)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Charoen Pokphand Foods PCL operates in agro-industrial and integrated food businesses. The group’s business operations are located throughout Thailand and overseas. The businesses are divided into two main segments namely the livestock business which comprises chicken, duck and pigs and the aquaculture business comprises shrimp and fish. The two main businesses are vertically integrated, starting from sourcing raw materials for animal feed production, manufacturing animal feed, breeding animals, farming animals for commercial purposes, primary processing meat, producing ready-to-eat food products, and including operating food retail outlets and restaurants.
Stock Forecast FAQ
In the current month, CPOUF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CPOUF average analyst price target in the past 3 months is --.
-
Where Will Charoen Pokphand Foods PCL Stock Be In 1 Year?
According to analysts, the consensus estimate is that Charoen Pokphand Foods PCL share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Charoen Pokphand Foods PCL?
Analysts are divided on their view about Charoen Pokphand Foods PCL share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Charoen Pokphand Foods PCL is a Sell and believe this share price will rise from its current level to --.
-
What Is Charoen Pokphand Foods PCL's Price Target?
The price target for Charoen Pokphand Foods PCL over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CPOUF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Charoen Pokphand Foods PCL is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CPOUF?
You can purchase shares of Charoen Pokphand Foods PCL via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Charoen Pokphand Foods PCL shares.
-
What Is The Charoen Pokphand Foods PCL Share Price Today?
Charoen Pokphand Foods PCL was last trading at $0.75 per share. This represents the most recent stock quote for Charoen Pokphand Foods PCL. Yesterday, Charoen Pokphand Foods PCL closed at $0.75 per share.
-
How To Buy Charoen Pokphand Foods PCL Stock Online?
In order to purchase Charoen Pokphand Foods PCL stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Does Intel Stock Have Room to Grow?
Intel Corporation (NASDAQ:INTC)’s recent innovations, Xeon 6 SoC and Xeon®…
Is Walmart the Largest Retailer in the World?
For many years, Walmart (NYSE:WMT) has been the world’s largest…
Stock Ideas
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
44
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
45
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
50
GH alert for Mar 12
Guardant Health [GH] is up 1.1% over the past day.
Sell
44
TER alert for Mar 12
Teradyne [TER] is down 0.36% over the past day.
Buy
57
LMB alert for Mar 12
Limbach Holdings [LMB] is down 4.39% over the past day.
